Emergency Gynecologic Methotrexate Kit

 

 EmGYN kit m2

 

The Emergency Gynecologic Methotrexate Kit from Edge Pharma solves a major issue affecting hospitals and OB/GYN clinics. In facilities without a USP 800 compliant hazardous cleanroom, preparation and administration of Methotrexate is a challenge. With the EmGyn Emergency Gynecologic Methotrexate Kit, any hospital or clinic can now confidently administer adjustable patient-specific body surface area based doses of Methotrexate up to 125mg. As an FDA-Registered 503B Outsourcing Facility we are able to dispense EmGyn Kits without requiring patient names.

Emergency Gynecologic Methotrexate Kit comes prefilled with 5mL of Methotrexate 25 mg/mL in an administration syringe. The administration syringe is connected to a waste syringe through a closed system transfer device (CSTD). Body surface area based dosage is achieved by activating the CSTD, transferring the unneeded Methotrexate into the waste syringe, deactivating the CSTD, and then detaching the waste syringe from the system. The waste syringe can then be safely disposed of in an appropriate hazardous waste container, while the administration syringe now contains the desired amount of Methotrexate. Hence any dose up to 125mg can be selected and easily prepared for administration.

 Emergency Gynecology Methotrexate Kit detached

enlarge 25x28

 

EmGyn Kit Features

 

  • The simplest solution for Emergency Methotrexate Kit to comply with USP 800.
  • 125mg/5mL Methotrexate. Enables surface area dosing.
  • Ability to prepare any dosage up to 125mg without the need for hazardous cleanroom facilities. No compounding required.
  • Dispensed without Patient Names.
  • Includes closed system transfer device.

 

References

 

1) Cecchino, G.N., Araujo Júnior, E. & Elito Júnior, "Methotrexate for Ectopic Pregnancy: When and How," J. Arch Gynecol Obstet (2014) 290: 417. https://doi.org/10.1007/s00404-014-3266-9.

"In spite of new treatment modalities and improvement of diagnostic methods, ectopic pregnancy (EP) is still the leading cause of maternal death in the first trimester of pregnancy, accounting for 6-13% of all pregnancy-related deaths."

"In industrialized countries, up to 2% of all pregnancies are ectopic in location.

"Considering MTX in tubal pregnancy, it proved to be more effective in cases of low titers of beta-hCG and masses with a small diameter, although there is still no uniformity of these parameters. Additionally, non-tubal ectopic pregnancies are associated with greater morbidity and may require medical treatment with direct injection or systemic MTX, which have been used effectively."

 

Register To Order Online 

 

Register for an online ordering account to place a pre-order. Emergency Gynecology Methotrexate Kits will begin shipping in August.

Create an account to order

Log-In if you have an account